- Title:
Chair of Audit & Risk Committee - Time:
18:24:40 - Date:
17 Mar 2021 - Category:
Miscellaneous - ID:
6312S
GlaxoSmithKline plc
(the 'Company')
Chair of Audit & Risk Committee
Mr Charlie Bancroft succeeded Ms Judy Lewent as chair of the Company's Audit & Risk Committee on 13 March 2021. Ms Lewent will remain a Non-Executive Director of the Company and member of the Audit & Risk Committee and the other Board committees on which she sits until the conclusion of the 2021 Annual General Meeting due to be held on Wednesday 5 May 2021.
V A Whyte
Company Secretary
17 March 2021
Chair of Audit & Risk Committee18:24:4017 Mar 2021Miscellaneous6312S